These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Can RDW be used as a screening test for subclinical inflammation in children with FMF? Is RDW related to MEFV gene mutations? Parmaksız G; Noyan ZA Clin Rheumatol; 2023 Jan; 42(1):197-202. PubMed ID: 36103024 [TBL] [Abstract][Full Text] [Related]
5. As a new inflammatory marker for familial Mediterranean fever: neutrophil-to-lymphocyte ratio. Ahsen A; Ulu MS; Yuksel S; Demir K; Uysal M; Erdogan M; Acarturk G Inflammation; 2013 Dec; 36(6):1357-62. PubMed ID: 23794006 [TBL] [Abstract][Full Text] [Related]
6. Correlation of Secretory Activity of Neutrophils With Genotype in Patients With Familial Mediterranean Fever. Gohar F; Orak B; Kallinich T; Jeske M; Lieber M; von Bernuth H; Giese A; Weissbarth-Riedel E; Haas JP; Dressler F; Holzinger D; Lohse P; Neudorf U; Lainka E; Hinze C; Masjosthusmann K; Kessel C; Weinhage T; Foell D; Wittkowski H Arthritis Rheumatol; 2016 Dec; 68(12):3010-3022. PubMed ID: 27333294 [TBL] [Abstract][Full Text] [Related]
7. Usefulness of mean platelet volume and neutrophil-to-lymphocyte ratio for evaluation of children with Familial Mediterranean fever. Uluca Ü; Ece A; Şen V; Karabel D; Yel S; Güneş A; Tan I; Sabas M Med Sci Monit; 2014 Sep; 20():1578-82. PubMed ID: 25189760 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of hematological parameters in children with FMF. Yorulmaz A; Akbulut H; Taş SA; Tıraş M; Yahya İ; Peru H Clin Rheumatol; 2019 Mar; 38(3):701-707. PubMed ID: 30328023 [TBL] [Abstract][Full Text] [Related]
9. The role of neutrophil lymphocyte ratio to leverage the differential diagnosis of familial Mediterranean fever attack and acute appendicitis. Kucuk A; Erol MF; Senel S; Eroler E; Yumun HA; Uslu AU; Erol AM; Tihan D; Duman U; Kucukkartallar T; Solak Y Korean J Intern Med; 2016 Mar; 31(2):386-91. PubMed ID: 26864298 [TBL] [Abstract][Full Text] [Related]
10. [Familial Mediterranean Fever (FMF): from diagnosis to treatment]. Medlej-Hashim M; Loiselet J; Lefranc G; Mégarbané A Sante; 2004; 14(4):261-6. PubMed ID: 15745878 [TBL] [Abstract][Full Text] [Related]
11. S1000A12, Chitotriosidase, and Resolvin D1 as Potential Biomarkers of Familial Mediterranean Fever. Taylan A; Gurler O; Toprak B; Sisman AR; Yalcin H; Colak A; Sari I J Korean Med Sci; 2015 Sep; 30(9):1241-5. PubMed ID: 26339162 [TBL] [Abstract][Full Text] [Related]
12. Role of A-SAA in monitoring subclinical inflammation and in colchicine dosage in familial Mediterranean fever. Duzova A; Bakkaloglu A; Besbas N; Topaloglu R; Ozen S; Ozaltin F; Bassoy Y; Yilmaz E Clin Exp Rheumatol; 2003; 21(4):509-14. PubMed ID: 12942707 [TBL] [Abstract][Full Text] [Related]
13. Can Calprotectin Show Subclinical Inflammation in Familial Mediterranean Fever Patients? Asan G; Derin ME; Doğan HO; Bayram M; Şahin M; Şahin A J Korean Med Sci; 2020 Mar; 35(10):e63. PubMed ID: 32174062 [TBL] [Abstract][Full Text] [Related]
14. Concordance between CRP and SAA in familial Mediterranean fever during attack-free period: A study of 218 patients. Stankovic Stojanovic K; Hentgen V; Fellahi S; Georgin-Lavialle S; Amselem S; Grateau G; Bastard JP; Steichen O Clin Biochem; 2017 Mar; 50(4-5):206-209. PubMed ID: 27838405 [TBL] [Abstract][Full Text] [Related]
15. Assessment of neutrophil to lymphocyte ratio and mean platelet volume in pediatric familial Mediterranean fever patients. Basaran O; Uncu N; Celikel BA; Aydın F; Cakar N J Res Med Sci; 2017; 22():35. PubMed ID: 28461821 [TBL] [Abstract][Full Text] [Related]
16. Comparison of early versus late onset familial Mediterranean fever. Yasar Bilge NS; Sari I; Solmaz D; Senel S; Emmungil H; Kilic L; Yilmaz Oner S; Yildiz F; Yilmaz S; Ersozlu Bozkirli D; Aydin Tufan M; Yilmaz S; Yazisiz V; Pehlivan Y; Bes C; Yildirim Cetin G; Erten S; Gonullu E; Sahin F; Akar S; Aksu K; Kalyoncu U; Direskeneli H; Erken E; Sayarlioglu M; Cınar M; Kasifoglu T Int J Rheum Dis; 2018 Apr; 21(4):880-884. PubMed ID: 29314707 [TBL] [Abstract][Full Text] [Related]
17. MEFV gene compound heterozygous mutations in familial Mediterranean fever phenotype: a retrospective clinical and molecular study. Caglayan AO; Demiryilmaz F; Ozyazgan I; Gumus H Nephrol Dial Transplant; 2010 Aug; 25(8):2520-3. PubMed ID: 19934083 [TBL] [Abstract][Full Text] [Related]
18. Can the Thiol/Disulfide Imbalance Be a Predictor of Colchicine Resistance in Familial Mediterranean Fever? Omma A; Sandikci SC; Kücüksahin O; Alisik M; Erel O J Korean Med Sci; 2017 Oct; 32(10):1588-1594. PubMed ID: 28875601 [TBL] [Abstract][Full Text] [Related]
19. Higher thrombin activatable fibrinolysis inhibitor levels are associated with inflammation in attack-free familial Mediterranean fever patients. Bavbek N; Ceri M; Akdeniz D; Kargili A; Duranay M; Erdemli K; Akcay A; Guz G Ren Fail; 2014 Jun; 36(5):743-7. PubMed ID: 24580410 [TBL] [Abstract][Full Text] [Related]
20. Genotype-phenotype correlation in patients with familial Mediterranean fever in East Anatolia (Turkey). Albayrak F; Selcuk NY; Odabas AR; Cetinkaya R; Pirim I Genet Test Mol Biomarkers; 2010 Jun; 14(3):325-8. PubMed ID: 20373849 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]